{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:08:05Z","timestamp":1791083285553,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>PPAR\u03b3 is a ligand-binding transcription factor that has been reported to be implicated in lipid metabolism, immune function, and cellular growth and differentiation. It has been suspected to play a role in the pathophysiology of preeclampsia, although the mechanism is yet to be elaborated. This study aims to investigate the expression of PPAR\u03b3 in early onset preeclampsia (EOPE), late onset preeclampsia (LOPE), and normal pregnancy. We conducted this study using primary trophoblastic cell culture incubated with serum from EOPE, LOPE, and normal pregnancy. The expression of PPAR\u03b3 in these cells was analyzed using Western Blot. Statistical analysis was performed using one-way ANOVA and Bonferroni\u2019s post hoc test. p\u2009&lt;\u20090.05 is considered significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum from normal pregnant women and EOPE did not induce any difference in the expression of PPAR-\u03b3 (p\u2009&gt;\u20090.05). In contrast, expression of PPAR-\u03b3 was increased in those cells induced by serum from LOPE (p\u2009&lt;\u20090.001). Therefore, we conclude that hypothetically PPAR-\u03b3 might play role in the pathophysiology of LOPE but not in EOPE. Other possibility is the activity of PPAR-\u03b3 in EOPE is inversely correlated with its expression, therefore the high enzymatic activity of PPAR-\u03b3 is tightly regulated by attenuating its expression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13104-020-05029-x","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:25:03Z","timestamp":1585268703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Differences in expression of Peroxisome Proliferator-activated Receptor-\u03b3 in early-onset preeclampsia and late-onset preeclampsia"],"prefix":"10.1186","volume":"13","author":[{"given":"W.","family":"Permadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. I.","family":"Mantilidewi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Khairani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. A.","family":"Lantika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Ronosulistyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bayuaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"issue":"3","key":"5029_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130\u20137.","journal-title":"Semin Perinatol."},{"issue":"9741","key":"5029_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, Von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376(9741):631\u201344.","journal-title":"The Lancet."},{"issue":"3","key":"5029_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","volume":"204","author":"I Brosens","year":"2011","unstructured":"Brosens I, Pijnenborg R, Vercruysse L, Romero R. The, \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193\u2013201.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"5029_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bpobgyn.2010.10.009","volume":"25","author":"R Pijnenborg","year":"2011","unstructured":"Pijnenborg R, Vercruysse L, Brosens I. Deep placentation. Best Pract Res Clin Obstet Gynaecol. 2011;25(3):273\u201385.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"5029_CR5","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","volume":"35","author":"C Redman","year":"2014","unstructured":"Redman C, Sargent I, Staff A. IFPA Senior Award Lecture: making sense of pre-eclampsia\u2014two placental causes of preeclampsia? Placenta. 2014;35:S20\u20135.","journal-title":"Placenta"},{"issue":"6163","key":"5029_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332(6163):411.","journal-title":"Nature"},{"issue":"19","key":"5029_CR7","first-page":"30323","volume":"S0002\u20139378","author":"I Brosens","year":"2019","unstructured":"Brosens I, Brosens JJ, Muter J, Puttemans P, Benagiano G. Preeclampsia: the role of persistent endothelial cells in uteroplacental arteries. Am J Obstet Gynecol. 2019;S0002\u20139378(19):30323.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"5029_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","volume":"30","author":"G Burton","year":"2009","unstructured":"Burton G, Woods A, Jauniaux E, Kingdom J. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473\u201382.","journal-title":"Placenta"},{"issue":"1","key":"5029_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1385\/ENDO:19:1:103","volume":"19","author":"L Myatt","year":"2002","unstructured":"Myatt L. Role of placenta in preeclampsia. Endocrine. 2002;19(1):103\u201311.","journal-title":"Endocrine"},{"issue":"1","key":"5029_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ajog.2008.07.022","volume":"200","author":"CM Koopmans","year":"2009","unstructured":"Koopmans CM, Blaauw J, van Pampus MG, Rakhorst G, Aarnoudse JG. Abnormal endothelium-dependent microvascular dilator reactivity in pregnancies complicated by normotensive intrauterine growth restriction. Am J Obstet Gynecol. 2009;200(1):66.","journal-title":"Am J Obstet Gynecol"},{"key":"5029_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","volume":"161","author":"J Roberts","year":"1989","unstructured":"Roberts J, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5029_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/micc.12079","volume":"21","author":"LJ Brennan","year":"2014","unstructured":"Brennan LJ, Morton JS, Davidge ST. Vascular dysfunction in preeclampsia. Microcirculation. 2014;21(1):4\u201314.","journal-title":"Microcirculation."},{"issue":"4","key":"5029_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bcp.2015.04.012","volume":"95","author":"DA Shah","year":"2015","unstructured":"Shah DA, Khalil RA. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol. 2015;95(4):211\u201326.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"5029_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1515\/jpm.2011.098","volume":"39","author":"G Ogge","year":"2011","unstructured":"Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med. 2011;39(6):641\u201352.","journal-title":"J Perinat Med"},{"issue":"8","key":"5029_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","volume":"66","author":"D Raymond","year":"2011","unstructured":"Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497\u2013506.","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"5029_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","volume":"180","author":"CW Redman","year":"1999","unstructured":"Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2):499\u2013506.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5029_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/01.aoa.0000370514.00986.bf","volume":"30","author":"S Hern\u00e1ndez-D\u00edaz","year":"2010","unstructured":"Hern\u00e1ndez-D\u00edaz S, Toh S, Cnattingius S. Risk of preeclampsia in first and subsequent pregnancies: prospective cohort study. Obstetric Anesthesia Digest. 2010;30(2):98\u20139.","journal-title":"Obstetric Anesthesia Digest."},{"issue":"4","key":"5029_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","volume":"49","author":"H Stepan","year":"2007","unstructured":"Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension. 2007;49(4):818\u201324.","journal-title":"Hypertension"},{"issue":"6","key":"5029_CR19","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","volume":"109","author":"A-K Wikstr\u00f6m","year":"2007","unstructured":"Wikstr\u00f6m A-K, Larsson A, Eriksson UJ, Nash P, Nord\u00e9n-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol. 2007;109(6):1368\u201374.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"5029_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jri.2011.05.003","volume":"90","author":"T Fournier","year":"2011","unstructured":"Fournier T, Guibourdenche J, Handschuh K, Tsatsaris V, Rauwel B, Davrinche C, et al. PPAR\u03b3 and human trophoblast differentiation. J Reprod Immunol. 2011;90(1):41\u20139.","journal-title":"J Reprod Immunol"},{"issue":"5","key":"5029_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/bph.12069","volume":"168","author":"FP McCarthy","year":"2013","unstructured":"McCarthy FP, Delany AC, Kenny LC, Walsh SK. PPAR-\u03b3\u2013a possible drug target for complicated pregnancies. Br J Pharmacol. 2013;168(5):1074\u201385.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"5029_CR22","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1210\/jc.2004-0849","volume":"90","author":"LL Waite","year":"2005","unstructured":"Waite LL, Louie RE, Taylor RN. Circulating activators of peroxisome proliferator-activated receptors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab. 2005;90(2):620\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5029_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.placenta.2009.12.009","volume":"31","author":"S Holdsworth-Carson","year":"2010","unstructured":"Holdsworth-Carson S, Lim R, Mitton A, Whitehead C, Rice G, Permezel M, et al. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta. 2010;31(3):222\u20139.","journal-title":"Placenta"},{"key":"5029_CR24","doi-asserted-by":"publisher","DOI":"10.1017\/9781139696647","volume-title":"Experimental design for laboratory biologists","author":"SE Lazic","year":"2016","unstructured":"Lazic SE. Experimental design for laboratory biologists. Cambridge: Cambridge University Press; 2016."},{"issue":"1","key":"5029_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/jmf.13.1.39.44","volume":"13","author":"D Neale","year":"2003","unstructured":"Neale D, Demasio K, Illuzi J, Chaiworapongsa T, Romero R, Mor G. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonatal Med. 2003;13(1):39\u201344.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"5","key":"5029_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0197-2456(96)00106-7","volume":"17","author":"RJ Levine","year":"1996","unstructured":"Levine RJ, Esterlitz JR, Raymond EG, DerSimonian R, Hauth JC, Curet LB, et al. Trial of calcium for preeclampsia prevention (CPEP): rationale, design, and methods. Control Clin Trials. 1996;17(5):442\u201369.","journal-title":"Control Clin Trials"},{"issue":"6","key":"5029_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.HYP.0000188408.49896.c5","volume":"46","author":"JM Roberts","year":"2005","unstructured":"Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243\u20139.","journal-title":"Hypertension"},{"key":"5029_CR28","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.placenta.2010.11.023","volume":"32","author":"K Orendi","year":"2011","unstructured":"Orendi K, Kivity V, Sammar M, Grimpel Y, Gonen R, Meiri H, et al. Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia. Placenta. 2011;32:S49\u201354.","journal-title":"Placenta"},{"issue":"11","key":"5029_CR29","first-page":"47","volume":"9","author":"AY Pramatirta","year":"2016","unstructured":"Pramatirta AY, Laksono B, Fauziah PN, Anwar AD, Krisnadi SR, Retnoningrum DS, et al. Effects of low dose aspirin on caspase 3, TNF-\u03b1 and apoptotic index levels in preclampsia maternal serum-induced placental trophoblast cell line in vitro. J Pharm Tech Res. 2016;9(11):47\u201353.","journal-title":"J Pharm Tech Res"},{"issue":"1","key":"5029_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-015-0070-8","volume":"13","author":"L Li","year":"2015","unstructured":"Li L, Schust DJ. Isolation, purification and in vitro differentiation of cytotrophoblast cells from human term placenta. Reprod Biol Endocrinol. 2015;13(1):71.","journal-title":"Reprod Biol Endocrinol."},{"issue":"5","key":"5029_CR31","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2353\/ajpath.2010.100475","volume":"177","author":"S Kalkunte","year":"2010","unstructured":"Kalkunte S, Boij R, Norris W, Friedman J, Lai Z, Kurtis J, et al. Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am J Pathol. 2010;177(5):2387\u201398.","journal-title":"Am J Pathol"},{"key":"5029_CR32","doi-asserted-by":"publisher","first-page":"658520","DOI":"10.1155\/2008\/658520","volume":"2008","author":"JJ Bright","year":"2008","unstructured":"Bright JJ, Kanakasabai S, Chearwae W, Chakraborty S. PPAR regulation of inflammatory signaling in CNS diseases. PPAR Res. 2008;2008:658520.","journal-title":"PPAR Res"},{"issue":"6","key":"5029_CR33","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","volume":"123","author":"M Lehrke","year":"2005","unstructured":"Lehrke M, Lazar MA. The many faces of PPAR\u03b3. Cell. 2005;123(6):993\u20139.","journal-title":"Cell"},{"issue":"11","key":"5029_CR34","doi-asserted-by":"publisher","first-page":"e8055","DOI":"10.1371\/journal.pone.0008055","volume":"4","author":"MM Parast","year":"2009","unstructured":"Parast MM, Yu H, Ciric A, Salata MW, Davis V, Milstone DS. PPAR\u03b3 regulates trophoblast proliferation and promotes labyrinthine trilineage differentiation. PLoS ONE. 2009;4(11):e8055.","journal-title":"PLoS ONE"},{"issue":"8","key":"5029_CR35","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1517\/14728222.12.8.1049","volume":"12","author":"C Giaginis","year":"2008","unstructured":"Giaginis C, Spanopoulou E, Theocharis S. PPAR-\u03b3 signaling pathway in placental development and function: a potential therapeutic target in the treatment of gestational diseases. Expert Opin Ther Targets. 2008;12(8):1049\u201363.","journal-title":"Expert Opin Ther Targets."},{"issue":"2","key":"5029_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/19396368.2014.991881","volume":"61","author":"L Kadam","year":"2015","unstructured":"Kadam L, Kohan-Ghadr HR, Drewlo S. The balancing act\u2013PPAR-\u03b3\u2019s roles at the maternal-fetal interface. Syst Biol Reprod Med. 2015;61(2):65\u201371.","journal-title":"Syst Biol Reprod Med."},{"issue":"4","key":"5029_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1053\/plac.1999.0485","volume":"21","author":"K Marvin","year":"2000","unstructured":"Marvin K, Eykholt R, Keelan J, Sato T, Mitchell M. The 15-deoxy-\u039412, 14-prostaglandin J2 receptor, peroxisome proliferator activated receptor-\u03b3 (PPAR\u03b3) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta. 2000;21(4):436\u201340.","journal-title":"Placenta"},{"issue":"5","key":"5029_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jsgi.2005.03.004","volume":"12","author":"VA Rodie","year":"2005","unstructured":"Rodie VA, Young A, Jordan F, Sattar N, Greer IA, Freeman D. Human placental peroxisome proliferator-activated receptor \u03b4 and \u03b3 expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig. 2005;12(5):320\u20139.","journal-title":"J Soc Gynecol Investig"},{"issue":"8\u20139","key":"5029_CR39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1053\/plac.2002.0855","volume":"23","author":"Q Wang","year":"2002","unstructured":"Wang Q, Fujii H, Knipp G. Expression of PPAR and RXR isoforms in the developing rat and human term placentas. Placenta. 2002;23(8\u20139):661\u201371.","journal-title":"Placenta"},{"issue":"1","key":"5029_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1749-6632.2002.tb04601.x","volume":"973","author":"T Fournier","year":"2002","unstructured":"Fournier T, Pavan L, Tarrade A, Schoonjans K, Auwerx J, et al. The role of PPAR-\u03b3\/RXR-\u03b1 heterodimers in the regulation of human trophoblast invasion. Ann N Y Acad Sci. 2002;973(1):26\u201330.","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"5029_CR41","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.placenta.2009.09.006","volume":"30","author":"K Handschuh","year":"2009","unstructured":"Handschuh K, Guibourdenche J, Cocquebert M, Tsatsaris V, Vidaud M, Evain-Brion D, et al. Expression and regulation by PPAR\u03b3 of hCG \u03b1-and \u03b2-subunits: comparison between villous and invasive extravillous trophoblastic cells. Placenta. 2009;30(12):1016\u201322.","journal-title":"Placenta"},{"issue":"3","key":"5029_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1447-0756.2012.02010.x","volume":"39","author":"A Aksornphusitaphong","year":"2013","unstructured":"Aksornphusitaphong A, Phupong V. Risk factors of early and late onset pre-eclampsia. J Obstet Gynaecol Res. 2013;39(3):627\u201331.","journal-title":"J Obstet Gynaecol Res."},{"issue":"4","key":"5029_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/HYPERTENSIONAHA.107.107607","volume":"51","author":"B Huppertz","year":"2008","unstructured":"Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970\u20135.","journal-title":"Hypertension"},{"issue":"2","key":"5029_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","volume":"2","author":"JM Roberts","year":"2012","unstructured":"Roberts JM, Escudero C. The placenta in preeclampsia. Preg Hypertension: An Int J Women\u2019s Cardiovasc Health. 2012;2(2):72\u201383.","journal-title":"Preg Hypertension: An Int J Women\u2019s Cardiovasc Health."},{"issue":"3","key":"5029_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physiol.00043.2008","volume":"24","author":"A Wang","year":"2009","unstructured":"Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24(3):147\u201358.","journal-title":"Physiology."},{"key":"5029_CR46","doi-asserted-by":"publisher","first-page":"637251","DOI":"10.1155\/2014\/637251","volume":"2014","author":"K Levytska","year":"2014","unstructured":"Levytska K, Drewlo S, Baczyk D. PPAR-\u03b3 regulates trophoblast differentiation in the BeWo cell model. PPAR Res. 2014;2014:637251.","journal-title":"PPAR Res"},{"issue":"2","key":"5029_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1515\/jpm-2013-0039","volume":"42","author":"J Knabl","year":"2014","unstructured":"Knabl J, H\u00fcttenbrenner R, Hutter S, G\u00fcnthner-Biller M, Vrekoussis T, Karl K, et al. Peroxisome proliferator-activated receptor-gamma (PPAR\u03b3) is down regulated in trophoblast cells of gestational diabetes mellitus (GDM) and in trophoblast tumour cells BeWo in vitro after stimulation with PPAR\u03b3 agonists. J Perinat Med. 2014;42(2):179\u201387.","journal-title":"J Perinat Med"},{"issue":"2","key":"5029_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ab.2012.05.005","volume":"427","author":"JM del Bas","year":"2012","unstructured":"del Bas JM, Laos S, Caimari A, Crescenti A, Arola L. Detection of bioavailable peroxisome proliferator-activated receptor gamma modulators by a cell-based luciferase reporter system. Anal Biochem. 2012;427(2):187\u20139.","journal-title":"Anal Biochem"},{"issue":"3","key":"5029_CR49","doi-asserted-by":"publisher","first-page":"e0230000","DOI":"10.1371\/journal.pone.0230000","volume":"15","author":"S Hao","year":"2020","unstructured":"Hao S, You J, Chen L, Zhao H, Huang Y, Zheng L, et al. Changes in pregnancy-related serum biomarkers early in gestation are associated with later development of preeclampsia. PLoS ONE. 2020;15(3):e0230000.","journal-title":"PLoS ONE"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05029-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-020-05029-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-020-05029-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T20:14:46Z","timestamp":1616789686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05029-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5029"],"URL":"https:\/\/doi.org\/10.1186\/s13104-020-05029-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21591\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21591\/v1","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"19 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The use of the samples for research purposes was approved by the ethical review boards of the Health Research Ethics Committee University of Padjadjaran Bandung Indonesia. Consent to participate was not applicable because in this research used archived biological material.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}